SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-035993
Filing Date
2022-12-20
Accepted
2022-12-20 16:05:59
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 934727
2 ex31-1.htm EX-31.1 17410
3 ex31-2.htm EX-31.2 17408
4 ex32-1.htm EX-32.1 6629
5 ex32-2.htm EX-32.2 6802
  Complete submission text file 0001493152-22-035993.txt   5438148

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20220630.xsd EX-101.SCH 45247
7 XBRL CALCULATION FILE vvos-20220630_cal.xml EX-101.CAL 65335
8 XBRL DEFINITION FILE vvos-20220630_def.xml EX-101.DEF 153783
9 XBRL LABEL FILE vvos-20220630_lab.xml EX-101.LAB 346130
10 XBRL PRESENTATION FILE vvos-20220630_pre.xml EX-101.PRE 280817
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 810756
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 221474789
SIC: 3841 Surgical & Medical Instruments & Apparatus